The menopause-obesity axis in MASH progression: from estrogen decline to liver fibrosis

More on Metabolic dysfunction-associated steatohepatitis

• Nutrient deficits linked to higher metabolic risks in obesity

  Nutrients · 4 Oct 2026

• Three-protein combination eased chronic liver disease in rats

  Communications Biology · 6 Oct 2026

  

• Dasatinib and quercetin reduce liver fibrosis in a phase-2 MASH trial

  Nature Metabolism · 2 Oct 2026

• Cardiometabolic burden is linked to CVD and death in MASLD

  Frontiers in Nutrition · 4 Oct 2026